No insider purchase over the last 90 days. The latest, by ZOU Qifang, was filed 03 Jan 2025.
Every trade that managers of Arrail Group Ltd. disclose to HKEX is tracked on this page. The company sits in the Health Care sector. The last twelve months, up to 22 October 2026, brought 10 filings signed by 2 insiders.
Only sales appear on the open market, 8 sales in all totalling €27k, filed by 2 insiders. The largest single trade was a sale of €6,049 by ZOU Qifang, published on 3 December 2025.
Filings reach the HKEX feed a median of 9 days after the trade. This delay matters because a trade only becomes useful information once it is public. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives.
Compared with its exchange (1,314 companies, median 4 filings), a count of 10 filings is above the norm. Over the whole record (from 2023), the tally stands at 6 purchases and 112 sales.
For comparison within the same sector, see the insider buying recorded at UCB. Every figure here comes from the filings published by HKEX and describes the past, not future prices; it is not investment advice.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended March 2025 · cache
25 of 124 declarations
Arrail Group Ltd. is a company operating in the healthcare and pharmaceutical sector, specializing in dental services in China. It is listed on the Hong Kong Stock Exchange under the symbol XHKG.
Purchases our model currently ranks for the recommendations list.
All recommendations